Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

piramal pharma limited - halothane - unknown - halothane anaesthetic active 0.0 - active constituent

New Zealand - English - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - ergometrine maleate 0.5 mg/ml - solution for injection - 500 mcg/ml - active: ergometrine maleate 0.5 mg/ml excipient: maleic acid water for injection

New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - midazolam 5 mg/ml;   - solution for injection - 5 mg/ml - active: midazolam 5 mg/ml   excipient: hydrochloric acid sodium chloride sodium hydroxide water for injection - conscious sedation before diagnostic or surgical interventions carried out under local anaesthesia (intravenous administration), or in children intranasal or oral administration. long-term sedation in intensive care units (intravenous administration as bolus injection or continuous infusion).

New Zealand - English - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - oxytocin 10 iu/ml (added as 200 iu/ml solution.);   - solution for injection - 10 iu/ml - active: oxytocin 10 iu/ml (added as 200 iu/ml solution.)   excipient: acetic acid chlorobutanol ethanol sodium acetate trihydrate water for injection - antepartum: · induction of labour for medical reasons, e.g. in cases of post-term gestation, premature rupture of the membranes, pregnancy-induced hypertension (pre-eclampsia). · enhancement of labour in selected cases of uterine inertia. · syntocinon may also be indicated in early stage of pregnancy, as adjunctive therapy for management of incomplete, inevitable or missed abortion.

New Zealand - English - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - oxytocin 5 iu/ml (added as 200 iu/ml solution.);   - solution for injection - 5 iu/ml - active: oxytocin 5 iu/ml (added as 200 iu/ml solution.)   excipient: acetic acid chlorobutanol ethanol sodium acetate trihydrate water for injection - antepartum: · induction of labour for medical reasons, e.g. in cases of post-term gestation, premature rupture of the membranes, pregnancy-induced hypertension (pre-eclampsia). · enhancement of labour in selected cases of uterine inertia. · syntocinon may also be indicated in early stage of pregnancy, as adjunctive therapy for management of incomplete, inevitable or missed abortion.

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - buprenorphine hydrochloride 0.324 mg/ml equivalent to 0.3 mg/ml buprenorphine; buprenorphine hydrochloride 0.324 mg/ml equivalent to buprenorphine 0.3 mg/ml - solution for injection - 0.3 mg/ml - active: buprenorphine hydrochloride 0.324 mg/ml equivalent to 0.3 mg/ml buprenorphine excipient: glucose hydrochloric acid water for injection active: buprenorphine hydrochloride 0.324 mg/ml equivalent to buprenorphine 0.3 mg/ml excipient: glucose monohydrate hydrochloric acid water for injection - temgesic injection is indicated for the short-term (not more than one week) management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain. temgesic is not recommended for use in children. temgesic does not have an approved role in opioid dependence rehabilitation programmes.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

concord pharmaceuticals ltd - halothane - inhalation vapour - 1ml/1ml

New Zealand - English - Medsafe (Medicines Safety Authority)

apotex nz ltd - oxytocin 10 iu/ml equivalent to 16.7 microgram/ml - solution for injection - 10 iu/ml - active: oxytocin 10 iu/ml equivalent to 16.7 microgram/ml excipient: acetic acid chlorobutanol hemihydrate water for injection - antepartum: - induction of labour for medical reasons, e.g. in cases of post-term gestation, premature rupture of the membranes, pregnancy-induced hypertension (pre-eclampsia). - enhancement of labour in selected cases of uterine inertia. - oxytocin may also be indicated in early stage of pregnancy, as adjunctive therapy for management of incomplete, inevitable or missed abortion.

New Zealand - English - Medsafe (Medicines Safety Authority)

apotex nz ltd - oxytocin 5 iu/ml equivalent to 8.33 microgram/ml - solution for injection - 5 iu/ml - active: oxytocin 5 iu/ml equivalent to 8.33 microgram/ml excipient: acetic acid chlorobutanol hemihydrate water for injection - antepartum: - induction of labour for medical reasons, e.g. in cases of post-term gestation, premature rupture of the membranes, pregnancy-induced hypertension (pre-eclampsia). - enhancement of labour in selected cases of uterine inertia. - oxytocin may also be indicated in early stage of pregnancy, as adjunctive therapy for management of incomplete, inevitable or missed abortion.

Zimbabwe - English - Medicines Control Authority

piramal enterprises limited - halothane - liquid - 100%v/v